Healthcare & Life Sciences
Ovid Therapeutics
United Stateswww.ovidrx.com
Ovid Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Ovid Therapeutics
Ovid Therapeutics is a company headquartered in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ovid Therapeutics is a biopharmaceutical company developing therapies for rare neurological disorders, with clinical-stage programs targeting certain genetic epilepsies and neurodevelopmental conditions such as Angelman syndrome.
Explore Ovid Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.